Biosimilar Trastuzumab (Hertraz) Approved in IndiaBiosimilar Trastuzumab (Hertraz) Approved in India

Three months after the patent on Herceptin expired in India, a biosimilar trastuzumab has been approved there, with a launch planned in early 2014. International Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news